FDA Inspection 1018956 — Jan De Bleecker, MD., CI
The FDA completed an inspection of Jan De Bleecker, MD., CI on May 11, 2017 in Gent. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 11, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gent (Belgium)
Additional details
Clinical Investigator (CI)